Edge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Edge Asset Management's BMY Position: Q1 2017 in Review
Edge Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2017 at 172,497 shares worth $9.38M. The position accounts for 0.07% of the portfolio, ranked #209.
Edge Asset Management first reported a position in BMY in Q2 2013 and has held it in 16 quarters since. The position peaked at $25.9M in Q2 2016. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- Edge Asset Management held 172,497 shares of Bristol-Myers Squibb worth $9.38M as of Q1 2017.
- Edge Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2017.
- Bristol-Myers Squibb made up 0.07% of Edge Asset Management's portfolio in Q1 2017, its #209 holding.
- Edge Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 16 quarters since.
- Edge Asset Management's Bristol-Myers Squibb position peaked at $25.9M in Q2 2016.
- 1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.